| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/25/2010 | WO2010031813A1 Glycoside derivatives and uses thereof |
| 03/25/2010 | WO2010031248A1 Thiazolium salt compound and the use of treating the protein aging disease |
| 03/25/2010 | WO2010006123A3 19-nor-vitamin d analogs with 1,2-dihydrofuran ring |
| 03/25/2010 | WO2010006121A3 19-nor-vitamin d analogs with 3,2-dihydrofuran ring |
| 03/25/2010 | WO2009153496A3 Ppar agonist compounds and preparation and uses thereof for treating diabetes and/or dyslipidemia |
| 03/25/2010 | WO2009150550A9 Genetic component of complications in type 2 diabetes |
| 03/25/2010 | WO2009149397A3 Respiratory syncytial virus renders dendritic cells tolerogenic |
| 03/25/2010 | WO2009148287A3 Novel α-iso-cubebene compound extracted from schisandra chinensis and composition containing the compound as active ingredient for preventing and treating inflammatory diseases |
| 03/25/2010 | WO2009146540A8 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 03/25/2010 | WO2009146539A8 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
| 03/25/2010 | WO2009145814A3 Pyrimidines and pyridines useful as inhibitors of protein kinases |
| 03/25/2010 | WO2009141533A3 Pyrrole derivatives, preparation of same and therapeutic application thereof as cannabinoid cb1 receptor antagonists |
| 03/25/2010 | US20100076094 Formulation containing phosphate derivatives of electron transfer agents |
| 03/25/2010 | US20100076088 Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 03/25/2010 | US20100076086 Process for the preparation of o-desmethyl venlafaxine |
| 03/25/2010 | US20100076084 Method of Treating Metabolic Disorders, Especially Diabetes, or a Disease or Condition Associated with Diabetes |
| 03/25/2010 | US20100076070 Forskolin Compositions and Methods For Administration |
| 03/25/2010 | US20100076059 METHOD OF EVALUATING COMPOUND EFFICACIOUS IN TREATING OBESITY BY USING Slc25a10 |
| 03/25/2010 | US20100076050 Solid betalain compositions and methods |
| 03/25/2010 | US20100076041 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors |
| 03/25/2010 | US20100076039 Composition for the prevention and treatment of metabolic disorder containing benzazole derivatives as an active ingredient |
| 03/25/2010 | US20100076036 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| 03/25/2010 | US20100076033 Methods For Treating Hyperlipidemia with Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics |
| 03/25/2010 | US20100076027 Indazole or 4,5,6,7-tetrahydro-indazole derivatives |
| 03/25/2010 | US20100076024 Novel Compounds as Serine Protease Inhibitors |
| 03/25/2010 | US20100076021 Organic Compounds |
| 03/25/2010 | US20100076019 Alcohol free formulation of argatroban |
| 03/25/2010 | US20100076014 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 03/25/2010 | US20100076010 Alpha 1a-adrenoceptor antagonists |
| 03/25/2010 | US20100076002 Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions and Pharmaceutical Compositions |
| 03/25/2010 | US20100075997 Use of pkc inhibitors in transplantation |
| 03/25/2010 | US20100075989 Novel Compounds Having Selective Inhibiting Effect at GSK3 |
| 03/25/2010 | US20100075987 Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 03/25/2010 | US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics |
| 03/25/2010 | US20100075974 Heterocyclic gpr40 modulators |
| 03/25/2010 | US20100075964 Imidazole based lxr modulators |
| 03/25/2010 | US20100075962 Indol derivatives, the method for preparing thereof and composition for the prevention and treatment of metabolic disorder containing the same as an active ingredient |
| 03/25/2010 | US20100075961 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 03/25/2010 | US20100075950 Phenylpropanone modulators of dopamine receptor |
| 03/25/2010 | US20100075943 1-adamantylazetidin-2-one derivatives and drugs containing same |
| 03/25/2010 | US20100075937 Patient populations and treatment methods |
| 03/25/2010 | US20100075932 Novel salicylic anilides |
| 03/25/2010 | US20100075909 Peptide |
| 03/25/2010 | US20100075907 Neuromedin u receptor agonists and uses thereof |
| 03/25/2010 | US20100075900 Use of Nutritional Compositions for Preventing Disorders |
| 03/25/2010 | US20100075894 Reducing er stress in the treatment of obesity and diabetes |
| 03/25/2010 | US20100074978 Method of treatment and prevention of metabolic and digestion disorders and of pathological states associated therewith and products used therein |
| 03/25/2010 | US20100074969 Method of controlling blood sugar levels, insulin levels, cholesterol levels, body fat levels, and body weight by administering a nutrient fiber matrix |
| 03/25/2010 | US20100074955 Combination of NMDA-Receptor Ligand and a Compound With 5-HT6 Receptor Affinity |
| 03/25/2010 | US20100074951 Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors |
| 03/25/2010 | US20100074950 Anti-diabetic combinations |
| 03/25/2010 | US20100074949 Pharmaceutical composition and administration thereof |
| 03/25/2010 | US20100074933 Cell And Enzyme Compositions For Modulating Bile Acids, Cholesterol and Triglycerides |
| 03/25/2010 | US20100074900 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |
| 03/25/2010 | US20100074888 Animal having modification in mgat2 gene |
| 03/25/2010 | US20100074872 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota |
| 03/25/2010 | CA2737831A1 Glucoside derivatives and uses thereof as sglt inhibitors |
| 03/25/2010 | CA2737830A1 Glycoside derivatives and uses thereof |
| 03/24/2010 | EP2166093A1 Pharmaceutical composition for enzyme replacement therapy |
| 03/24/2010 | EP2166087A2 FAD4, FAD5, FAD5-2 et FAD6, fatty acid desaturase family members and uses thereof |
| 03/24/2010 | EP2166010A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 03/24/2010 | EP2166009A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 03/24/2010 | EP2166008A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 03/24/2010 | EP2166000A1 7-, 8- and 9-substituted tetracycline compounds |
| 03/24/2010 | EP2165707A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 03/24/2010 | EP2165610A1 Tympanites ventriculi-controlling agent for ruminant animals |
| 03/24/2010 | EP2165609A1 Rumen fermentation improving agent |
| 03/24/2010 | EP2164519A2 Long-acting polymeric prodrugs of exendin |
| 03/24/2010 | EP2046791B1 Urea derivatives of tropane, their preparation and their therapeutic application |
| 03/24/2010 | EP1644357B9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/24/2010 | EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/24/2010 | EP1112005B2 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid |
| 03/24/2010 | EP1003370B1 Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 03/24/2010 | CN101679979A Administering antisense oligonucleotides complementary to human apolipoprotein b |
| 03/24/2010 | CN101679445A Pyrimidinedione derivatives and methods of use thereof |
| 03/24/2010 | CN101679433A Novel adenine compound |
| 03/24/2010 | CN101679421A New imidazo[ 4,5-b]pyridine-7-carboxamides 704 |
| 03/24/2010 | CN101679405A 2-aminopyridine analogs as glucokinase activators |
| 03/24/2010 | CN101679368A aryloxazole, aryloxadiazole and benzimidazole derivatives |
| 03/24/2010 | CN101679365A Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 03/24/2010 | CN101679364A heteroarylamide pyrimidone compounds |
| 03/24/2010 | CN101679348A 5-pyridinone substituted indazoles |
| 03/24/2010 | CN101679322A Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
| 03/24/2010 | CN101679317A Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid r |
| 03/24/2010 | CN101679309A Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound |
| 03/24/2010 | CN101679306A Heteroarylamide pyrimidone derivatives |
| 03/24/2010 | CN101679304A Pyridazine-, pyridine- and pyrane-derivatives as GPBAR1 agonisis |
| 03/24/2010 | CN101679298A fused bicyclic heteroaryl derivatives |
| 03/24/2010 | CN101679297A lxr and fxr modulators |
| 03/24/2010 | CN101679288A Indazoles used to treat estrogen receptor beta mediated disorders |
| 03/24/2010 | CN101679260A 4,4-disubstituted piperidine derivatives |
| 03/24/2010 | CN101679250A Ppar活性化合物 Ppar active compounds |
| 03/24/2010 | CN101679236A Process for the preparation of ezetimibe and derivatives thereof |
| 03/24/2010 | CN101678055A Supplemention of maternal diet |
| 03/24/2010 | CN101678051A Agent for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor |
| 03/24/2010 | CN101678043A Composition for promoting ketone compound formation |
| 03/24/2010 | CN101678039A Mixture and method for reducing cholesterol using hydrophobic microparticles |
| 03/24/2010 | CN101678025A Tetrahydrobiopterin compositions, and methods of measuring |
| 03/24/2010 | CN101678022A 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 03/24/2010 | CN101678019A piperidine/piperazine derivatives |